Opposing effects of thapsigargin on the survival of developing cerebellar granule neurons in culture.
Elevated levels of potassium (K+) promote maturation and survival of cerebellar granule neurons in culture. When switched from a culture medium containing high K+ (25 mM) to one with low K+ (5 mM) mature granule neurons undergo death by apoptosis. The mechanism by which high K+ promotes neuronal survival (and conversely inhibits apoptosis) is unclear. Several pieces of evidence indicate that an increase in intracellular calcium (Ca2+) resulting from depolarization mediated-influx of extracellular Ca2+ is necessary. We examined the effect of thapsigargin on granule neuron cultures. Thapsigargin is an inhibitor of the endoplasmic reticular Ca2+ ATPase causing a depletion of Ca2+ from internal stores. This treatment would therefore be expected to raise intracellular cytosolic Ca2+ without membrane depolarization. We find that treatment of mature neurons with thapsigargin at doses > or = 5 nM inhibits death resulting from the lowering of extracellular K+. The survival effect of thapsigargin was not affected by inhibitors of extracellular Ca2+ influx including nifedipine, verapamil, methoxyverapamil, Mg2+, and Ni2+, nor was it inhibited by the NMDA receptor antagonist, MK801. We have further examined whether thapsigargin could substitute for elevated K+ during the maturation of granule cells. Unexpectedly, treatment of younger (immature) neuronal cultures with the same dose of thapsigargin (5 nM) induced cell death. DNA fragmentation analysis suggested that death was due to apoptosis and not toxicity. As observed with the survival effect on mature neurons, the lethal effect of thapsigargin on immature granule cells was not prevented by inhibitors of Ca2+ influx.
Levick
V
V
Department of Physiology and Neurobiology, University of Connecticut, Storrs 06269, USA.
Coffey
H
H
D'Mello
S R
SR
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D002118:Calcium / Q000378:metabolism*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D000252:Calcium-Transporting ATPases / Q000037:antagonists & inhibitors*; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D016922:Cellular Senescence / Q000187:drug effects; D002531:Cerebellum / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D004721:Endoplasmic Reticulum / Q000187:drug effects / Q000201:enzymology; D009474:Neurons / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D010946:Plants, Medicinal; D051381:Rats; D017208:Rats, Wistar; D013729:Terpenes / Q000494:pharmacology*; D019284:Thapsigargin
D002121:Calcium Channel Blockers; D013729:Terpenes; D019284:Thapsigargin; D000252:Calcium-Transporting ATPases; D002118:Calcium